Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,949
-$21,828 QoQ
Shares Held
33
-65.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,345
of 1,375 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Activest Wealth Management holds $3,677,653 across 13 Drug Manufacturers - General names. AMGN ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,573 | $3,086,133 | |
| 2 | PFE |
Pfizer Inc
|
8,877 | $213,758 | |
| 3 | MRK |
Merck & Co., Inc.
|
793 | $101,900 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,389 | $80,034 | |
| 5 | NVO |
Novo Nordisk A S
|
1,596 | $76,512 | |
| 6 | JNJ |
Johnson & Johnson
|
259 | $65,778 | |
| 7 | ABBV |
AbbVie Inc.
|
100 | $25,164 | |
| 8 | AMGN |
Amgen Inc
This page
|
33 | $11,949 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,949 | 33 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $33,777 | 96 | Shares | Sole | 2026-04-15 | |
| 2025-09-30 | $14,110 | 50 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $29,596 | 106 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $33,024 | 106 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $781 | 3 | Shares | Sole | 2025-01-28 | |
| 2022-06-30 | $3,406 | 14 | Shares | Sole | 2022-10-13 | |
| No filing history on record for this holder in this stock. | ||||||